contextflow – Weekly Recap

contextflow is the focus of this weekly summary, which reviews notable developments in its lung imaging AI business. The company is emphasizing research indicating that its deep learning–based emphysema quantification on low-dose CT may outperform traditional Hounsfield unit and %LAV−950 methods in both accuracy and risk prediction.

A Zurich research group compared contextflow’s algorithm with conventional techniques in COPD patients, finding stronger and more consistent correlations with lung function metrics such as FEV and KCO, particularly on soft tissue kernel reconstructions. These results suggest the technology could enhance routine CT analysis and AI-assisted diagnostics in clinical environments.

During the week, contextflow also underscored that lung cancer screening can identify serious comorbidities such as emphysema and interstitial lung disease, positioning its software to go beyond standard nodule detection. Its AI-based emphysema detection is promoted as delivering more accurate and consistent quantification while capturing incidental ILD findings within the same platform, potentially improving workflow efficiency.

In parallel, the company highlighted its collaboration with RevealDx on RevealAI-Lung, a computer-aided diagnosis tool focused on malignancy scoring for lung nodules. By analyzing hundreds of radiomic features not visible to the naked eye and comparing them with nodules of known outcomes, the CADx solution is intended to refine malignancy risk assessment across screening and routine workflows.

Contextflow is also targeting Germany’s upcoming national lung cancer screening program via a strategic partnership with Mint Medical, combining nodule detection and tracking, emphysema quantification and structured reporting. This “invisible” AI layer is designed to integrate into standard radiology workflows, supporting efficiency, standardization and reimbursement-oriented documentation for large-scale screening providers.

The company plans to showcase its capabilities at the RöKo 2026 radiology congress in Leipzig, using demos and a booth presence to engage potential customers and partners. Overall, the week highlighted contextflow’s strategy of pairing research-backed performance with workflow-centric integrations and collaborations to strengthen its competitive position in AI-driven lung imaging and screening.